UBS Group’s GMO Beyond China ETF BCHI Stock Holding History

UBS Group’s Portfolio BCHI Stock Details BCHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-118	Closed	-$3.6K	–	11516
2025 Q4	$3.6K	Buy	+118	New	+$3.54K	﹤0.01%	8987
2025 Q2	–	Sell	-24	Closed	-$583	–	11109
2025 Q1	$583	Buy	+24	New	+$593	﹤0.01%	9723

Other funds holding BCHI

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hara Capital Bellevue, Washington $200M AUM 49.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group's BCHI Position: Q1 2026 in Review

UBS Group sold out of GMO Beyond China ETF (BCHI) in Q1 2026, closing a stake of 118 shares — an estimated $3.6K sold.

UBS Group first reported a position in BCHI in Q1 2025 and held it in 2 quarters. The position peaked at $3.6K in Q4 2025. 5 funds tracked by Wall St. Rank hold BCHI as of Q1 2026.

UBS Group reported no remaining GMO Beyond China ETF position as of Q1 2026 after selling out during the quarter.
UBS Group sold 118 GMO Beyond China ETF shares in Q1 2026, an estimated $3.6K.
UBS Group first reported a position in GMO Beyond China ETF in Q1 2025 and held it in 2 quarters.
UBS Group's GMO Beyond China ETF position peaked at $3.6K in Q4 2025.
5 funds tracked by Wall St. Rank held GMO Beyond China ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.